Home › Funds › Caption Management, LLC › PCVX

Caption Management, LLC position in PCVX

VAXCYTE INC · Health Care

Caption Management, LLC reported holding 649,700 shares of PCVX (VAXCYTE INC) in its Q2 2026 13F filing — a position valued at US$37.8M, representing 0.64% of its reported portfolio and ranking #30 among its reported holdings. Caption Management, LLC has disclosed PCVX holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)649.70K sh
Reported value held$37.77M
Portfolio Weight0.64%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caption Management, LLC's PCVX position evolved

Caption Management, LLC first disclosed a stake in PCVX in Q2 2024 at 22,500 shares (US$1.7M). The position peaked in Q2 2026 at 649,700 shares, worth US$37.8M. Across 8 filings, Caption Management, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 649,700 shares valued at US$37.8M — an increase of 346,700 shares quarter over quarter.. Notable position changes include a 96% increase in Q3 2024 (shares fell 28% over the following quarter), a 910% increase in Q1 2026 (shares were roughly flat over the following quarter), a 114% increase in Q2 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 22.50K $1.70M New
Q3 2024 44.00K $5.03M Add
Q4 2024 30.00K $2.46M Reduce
Q1 2025 25.00K $944.00K Reduce
Q3 2025 50.00K $1.80M New
Q4 2025 30.00K $1.38M Reduce
Q1 2026 303.00K $17.61M Add
Q2 2026 649.70K $37.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 36 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has Caption Management, LLC held PCVX?

Caption Management, LLC has disclosed PCVX holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is Caption Management, LLC's current position in PCVX?

As of Q2 2026, Caption Management, LLC holds 649.70K shares of PCVX (VAXCYTE INC), valued at $37.77M, representing 0.64% of its reported portfolio and ranking #30.

Has Caption Management, LLC been buying or selling PCVX?

In the latest 13F filing (Q2 2026), Caption Management, LLC increased its position in PCVX. The position peaked in Q2 2026 at 649.70K shares.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.